• PDA TR 79

PDA TR 79

  • Technical Report No. 79 (TR 79) Particulate Matter Control in Difficult to Inspect Parenterals
  • Report / Survey by Parenteral Drug Association, 03/01/2018
  • Category: PDA

$325.00 $163.00

PDA Technical Report No. 79, Particulate Matter Control in Difficult to Inspect Parenterals describes best practices for difficult to inspect parenteral (DIP) product lifecycle management, destructive testing, and trending to supplement portions of the guidance given in USP General Chapter<1790>: Visible Particulates in Injection. In 2015, the PDA Task Force on Particulate Matter Control in Difficult to Inspect Parenterals initiated an industry survey on DIP products. literature, pharmacopeial references, and the collective expertise of Task Force contributors form the basis for the information provided in this technical report. This Technical Report is intended to provide logical pathways to DIP product inspection and testing to support continual process improvement in the industry.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 57

PDA TR 57

Technical Report No. 57 (TR 57) Analytical Method Validation and Transfer for Biotechnology Products..

$163.00 $325.00

PDA TR 58

PDA TR 58

Technical Report No. 58 (TR 58) Risk Management for Temperature-Controlled Distribution..

$163.00 $325.00

PDA TR 59

PDA TR 59

Technical Report No. 59 (TR 59) Utilization of Statistical Methods for Production Monitoring..

$163.00 $325.00

PDA TR 29

PDA TR 29

Technical Report 29, Revised 2012 (TR 29) Points to Consider for Cleaning Validation..

$163.00 $325.00